Claim Missing Document
Check
Articles

Found 2 Documents
Search

Squamous Cell Carcinoma of External Auditory Canal with Intracranial Infiltration Damayanthi, M. Ayu Dwi; Nuaba, I Gde Ardika; Suanda, I Ketut; Widiantari, Ida Ayu Alit
Jurnal Sehat Indonesia (JUSINDO) Vol. 7 No. 2 (2025): Jurnal Sehat Indonesia (JUSINDO)
Publisher : CV. Publikasi Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59141/.v7i2.362

Abstract

Squamous cell carcinoma of external auditory canal (SCC EAC) is a rare malignancy with  the incidence of  <0.2% of all malignancies of the head and neck region. This disease often mimics the features of other diseases as in chronic suppurative otitis media of the dangerous type with cholesteatoma. SCC EAC the most common malignancy pathology, reaching 90% of malignancies in the temporal bone and external auditory canal. This case report describes a patient with SCC in EAC with infiltration to intracranial. A 42 years old man with a history of discharge and blood from his left ear. Based on the history, clinical presentation and Computed Tomography (CT) Scan of the mastoid, found there was a mass in the left ear with intracranial infiltration. The results of histopathological examination obtained SCC EAC stage IV (T4N2M0) + infiltration of the cerebellum region S + non-communicating hydrocephalus. The patient already done a surgery. This case represents a rare presentation of SCC EAC with intracranial involvement in a relatively young patient (42 years), which is uncommon as most cases occur in patients aged 60-69 years. The aggressive nature with cerebellar infiltration and non-communicating hydrocephalus demonstrates the importance of early detection and multidisciplinary management. This case contributes to the limited literature on advanced SCC EAC with CNS involvement and emphasizes the need for comprehensive staging and aggressive surgical intervention.
Clinical and Histopathological Profile of Nasopharyngeal Carcinoma Patients in the Department of Otolaryngology-Head and Neck Surgery at Prof. Dr. I.G.N.G. Ngoerah General Hospital in 2022 – 2024 Diahswari Widyadari, Kadek Santi; Setiawathi, Ni Putu; Widiantari, Ida Ayu Alit
Eduvest - Journal of Universal Studies Vol. 5 No. 10 (2025): Eduvest - Journal of Universal Studies
Publisher : Green Publisher Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59188/eduvest.v5i10.52179

Abstract

Backgrounds: Nasopharyngeal carcinoma (NPC) is a form of carcinoma of the nasopharyngeal epithelium, where NPC is 6th as the most common carcinoma in Indonesia. This research aimed to find and get to know the clinical and histopathological profile of NPC patients in the Department of Otolaryngology-Head and Neck Surgery at Prof. Dr. I.G.N.G. Ngoerah General Hospital. Methods: This study is a descriptive observational study with a cross-sectional approach, conducted to determine the clinical and histopathological profile of NPC patients. Using total sampling method, data collection was carried out in May 2025 done by observing secondary data in the form of electronic medical records. The inclusion criteria of this study were patients diagnosed with NPC, patients could be from both male or female, patients of all ages, patients that have underwent examination for staging. Results: There were 186 NPC patients in this study. Patients diagnosed with NPC are more frequent in men (69,35%), in the age group of 45-54 years (37,63%), experiencing lump in the neck (68,82%), have histopathological features of undifferentiated cell carcinoma (98,92%), most patients were in the stage IVA (39,24%). Conclusion: NPC patients come with various sociodemographic backgrounds and different clinical conditions. This study found that NPC is more frequent in men than women, commonly diagnosed in the fourth and fifth decade of life, most patients experiencing lump in the neck. This study also found that the most common histopathological features were undifferentiated cell carcinoma. Most patients were in the stage IVA.